Results 301 to 310 of about 4,678,570 (340)

Clinical Characteristics of Parkinsonism in HTLV‐1‐Associated Myelopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Human T‐lymphotropic virus type 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is the classic neurological manifestation of HTLV‐1 infection; however, this virus has also been associated with other neurological disorders. Concurrent parkinsonism is relatively rare and presents diagnostic challenges.
Mika Dozono   +8 more
wiley   +1 more source

Cohort Profile: The ORIGINS pregnancy and birth cohort

open access: yesInternational Journal of Epidemiology
Jacqueline Davis   +7 more
openaire   +3 more sources

Understanding Mechanisms of Whole Brain and Regional Grey Matter Atrophy in Children With MOGAD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate the mechanisms driving whole brain and regional grey matter (GM) volume changes along with their clinical correlates in paediatric myelin oligodendrocyte glycoprotein antibody (MOG‐Ab)–associated disease (MOGAD). Methods One‐hundred‐nine paediatric MOGAD patients from two UK centres underwent MRI at attack nadir and ...
Ermelinda De Meo   +14 more
wiley   +1 more source

P357: Assessing discrepancies between genetic variants and clinical diagnosis in Marfan syndrome through All of Us

open access: yesGenetics in Medicine Open
Anirudh Kesanapally   +6 more
doaj  

Systematically identification of survival-associated eQTLs in a Japanese kidney cancer cohort. [PDF]

open access: yesPLoS Genet
Song X   +9 more
europepmc   +1 more source

Symptom burden in end-stage liver disease: a prospective cohort study of the symptoms experienced by patients and the role of palliative care. [PDF]

open access: yesTherap Adv Gastroenterol
Oliveira HM   +8 more
europepmc   +1 more source

In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock   +8 more
wiley   +1 more source

Depression and Untreated Dental Caries Among the Azar Cohort Population: A Cross-Sectional Study. [PDF]

open access: yesInt Dent J
Katebi K   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy